Ultrasonographic Evaluation of Fetal Adrenal Gland in Cases of Threatened Preterm Labor
NCT ID: NCT03251794
Last Updated: 2018-06-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2017-03-01
2018-04-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Prematurity causes 70% of fetal/neonatal deaths. 11.4% of births are at \< 37 weeks' gestation. The rate of prematurity increases dramatically with the number of fetuses - singletons 10%; twins 54.9%; and triplets 93.6%
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fetal Adrenal Gland Volume Estimation in Prediction of Preterm Birth
NCT02339623
Prediction of Fetal Lung Maturity
NCT03159234
Fetal Renal Artery Doppler in Patients With Preeclampsia
NCT06395974
Dexamethasone on Fetal and Uteroplacental Doppler
NCT02662790
Pulmonary Artery Doppler in Preeclamptic Mothers
NCT06755073
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
threatened preterm labor
women presented to the reception unit from 28-37 weeks by regular contractions and opened cervix
three dimensional ultrasound
evaluation of the suprarenal glands
color Doppler
Doppler evaluation of the suprarenal artery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
three dimensional ultrasound
evaluation of the suprarenal glands
color Doppler
Doppler evaluation of the suprarenal artery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. women diagnosed to having Threatened preterm labor.
1. presence of uterine contraction (at least 4 in 20 min or 8 in 60 min )
2. cervical effacement \<80 %
3. cervical dilatation \<1 cm
Exclusion Criteria
2. maternal medical complications,
3. presence of fetal heart rate abnormalities at enrollment.
4. Preterm Premature rupture of membranes
5. Placenta previa
6. Lower urinary tract infection or genital infection
7. Fetal congenital anomaly
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Mohamed Abbas
principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assiut Faculty of Medicine
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FAGE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.